reports
Microsoft Cloud Growth Speeds Up in Singapore, Malaysia
SINGAPORE & KUALA LUMPUR, Malaysia--(BUSINESS WIRE)-- Companies in Singapore and Malaysia are accelerating their adoption of Microsoft cloud platforms as their efforts to improve customer and employee experience mature, according to a new research report published today by Information Services Group () (Nasdaq: ), a leading global technology research and advisory firm. The 2024 ISG Provider Lens™ Microsoft Cloud Ecosystem report for Singapore and Malaysia finds more enterprises in the region are embracing Microsoft’s expanding lineup of platforms and seeking services for Microsoft 365, Azure...
- Jonathan Koh
Keppel Pacific Oak US REIT (KORE SP) - 1Q24: Resilient Portfolio Provi...
KORE’s 1Q24 was resilient, with stable NPI of US$21.0m and portfolio occupancy of 90.1%. Leasing momentum is strong with an early renewal by Ball Aerospace (second-largest tenant) and expansion by Spectrum (fifth-largest tenant). The suspension of distribution provides funding for necessary capex and helps keep KORE’s leverage below 45% to ensure continued support from banks for refinancing. KORE trades at 2026 distribution yield of 30.7% and P/NAV of 0.20x (80% discount to NAV). Maintain BUY. T...
Intra-Cellular Therapies Prices Public Offering of Common Stock
Intra-Cellular Therapies Prices Public Offering of Common Stock NEW YORK, April 17, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) (“Intra-Cellular Therapies”), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced the pricing of its previously announced underwritten public offering of 6,849,316 shares of its common stock at a public offering price of $73.00 per share. All of the shares in the offering will be sold by Intra-Cellular Therapies, with gross proceeds to I...
- Valens Research
- Limartha Adhiputra
- Maskun Ramli
Moody's Ratings assigns Aa1 to City & County of San Francisco, CA's 20...
Moody's Ratings (Moody's) has assigned a Aa1 rating to the City and County of San Francisco, CA's $213.8 million Refunding Certificates of Participation, Series 2024-R1 (Multiple Capital Improvement Projects) (Tax Exempt). Moody's maintains a Aaa issuer rating for the city, as well as Aa1 and Aa2 ra...
Moody's Ratings affirms Azalea TopCo's B3 CFR, outlook changed to stab...
Moody's Ratings affirmed the B3 corporate family ratings ("CFR") and B3-PD Probability of Default ratings ("PDR") of Azalea TopCo, Inc. ("PG Forsta") Moody's Ratings concurrently assigned instrument level ratings of B3 to the company's new senior secured first lien credit facilities that includes a ...
Moody's Ratings upgrades Stormont-Vail HealthCare (KS) to A1; outlook ...
Moody's Ratings (Moody's) has upgraded Stormont-Vail HealthCare's (KS)(SVH) issuer rating to A1 from A2 and revised the outlook to stable from positive at the new rating level. Total debt outstanding was $181 million at fiscal yearend 2023 (September 30). The upgrade to the A1 reflects the expecte...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.